この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2004/6/181 分で読めます
Notice of Approval of Abbreviated New Animal Drug Application; Dexamethasone Sodium Phosphate Injection
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration's Center for Veterinary Medicine (CVM) is providing notice that it has approved an original abbreviated new animal drug application (ANADA) filed by Cross Vetpharm Group Ltd. The ANADA provides for the veterinary prescription use of dexamethasone sodium phosphate injectable solution as a rapid adrenal glucocorticoid and/or anti-inflammatory agent in horses. The applicable sections of the regulations did not require amendment.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →